• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted

STN#: 125419
Proper Name: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
Manufacturer: ID Biomedical Corporation of Quebec

Indication

  • For active immunization for the prevention of disease caused by the influenza A virus H5N1 subtype contained in the vaccine. Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted is approved for use in persons 18 years of age and older at increased risk of exposure to the influenza A virus H5N1 subtype contained in the vaccine